Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 759.85M | 826.42M | 769.05M | 745.34M | 598.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 759.85M | 826.42M | 769.05M | 745.34M | 598.12M |
| Cost of Revenue | 234.07M | 254.63M | 246.13M | 242.77M | 195.35M |
| Gross Profit | 525.79M | 571.80M | 522.92M | 502.58M | 402.77M |
| SG&A Expenses | 297.77M | 304.78M | 284.19M | 303.47M | 242.74M |
| Depreciation & Amortization | 29.53M | 29.36M | 29.84M | 30.19M | 28.80M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 597.87M | 624.93M | 598.23M | 616.17M | 499.86M |
| Operating Income | 161.98M | 201.49M | 170.82M | 129.17M | 98.26M |
| Income Before Tax | 157.07M | 169.23M | 143.99M | 188.17M | 103.67M |
| Income Tax Expenses | 32.77M | 28.64M | 25.03M | -14.67M | 28.21M |
| Earnings from Continuing Operations | 124.30M | 140.59M | 118.97M | 202.85M | 75.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.30M | 140.59M | 118.97M | 202.85M | 75.46M |
| EBIT | 161.98M | 201.49M | 170.82M | 129.17M | 98.26M |
| EBITDA | 231.93M | 270.31M | 242.02M | 199.85M | 163.98M |
| EPS Basic | 0.92 | 1.05 | 0.88 | 1.50 | 0.55 |
| Normalized Basic EPS | 0.77 | 0.92 | 0.81 | 0.60 | 0.48 |
| EPS Diluted | 0.90 | 1.02 | 0.88 | 1.49 | 0.54 |
| Normalized Diluted EPS | 0.76 | 0.91 | 0.80 | 0.60 | 0.47 |
| Average Basic Shares Outstanding | 135.36M | 134.41M | 134.50M | 135.21M | 136.76M |
| Average Diluted Shares Outstanding | 138.19M | 136.57M | 135.39M | 136.50M | 139.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |